SOPH
Sophia Genetics SA
NASDAQ: SOPH · HEALTHCARE · HEALTH INFORMATION SERVICES
$5.28
+5.60% today
Updated 2026-04-29
Market cap
$358.34M
P/E ratio
—
P/S ratio
4.64x
EPS (TTM)
$-1.17
Dividend yield
—
52W range
$3 – $6
Volume
0.1M
Sophia Genetics SA (SOPH) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $76.62M | $51.66M | $132.12M | $320.17M | $243.84M | $206.16M | $155.31M |
| Cash & equivalents | $53.91M | $18.07M | $74.63M | $192.96M | $161.31M | $123.25M | $80.23M |
| Current assets | $62.72M | $33.76M | $109.69M | $282.86M | $196.25M | $148.05M | $99.41M |
| Total liabilities | $21.80M | $29.40M | $31.61M | $44.77M | $43.71M | $54.71M | $58.82M |
| Current liabilities | $11.40M | $19.26M | $21.59M | $28.60M | $26.81M | $35.62M | $26.80M |
| Long-term debt | $3.91M | $1.61M | $457000.00 | — | — | — | $13.24M |
| Shareholder equity | $54.82M | $22.25M | $100.51M | $275.40M | $200.13M | $151.44M | $96.49M |
| Retained earnings | $-64.55M | $-98.34M | $-137.68M | $-211.35M | $-298.80M | $-377.78M | $-440.28M |
| Accounts receivable | $5.10M | $9.71M | $7.85M | $7.09M | $8.05M | $15.21M | $8.69M |
| Inventory | $2.87M | $3.61M | $3.38M | $5.73M | $5.16M | $6.48M | $5.87M |
| Goodwill | $7.69M | $7.83M | $8.60M | $8.30M | $8.19M | $9.00M | $8.34M |